Recent OVID News
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 05/15/2026 12:03:35 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/14/2026 08:17:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/12/2026 11:06:58 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2026 11:04:29 AM
- Ovid Therapeutics Reports Business Updates and First Quarter 2026 Financial Results • GlobeNewswire Inc. • 05/12/2026 11:00:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/27/2026 09:12:01 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/27/2026 09:11:05 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/27/2026 09:01:17 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 04/21/2026 08:31:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/20/2026 12:16:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/09/2026 09:15:06 PM
- Ovid Therapeutics to Host Potassium-Chloride Co-transporter 2 (KCC2) Deep Dive R&D Event on Tuesday, April 14 • GlobeNewswire Inc. • 04/08/2026 12:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/18/2026 08:25:55 PM
- Ovid Therapeutics secures $60M funding to advance epilepsy drug programs • IH Market News • 03/18/2026 02:58:47 PM
- Ovid Therapeutics Announces New OV329 Data and Indication Expansion, Phase 1 Clearance for OV4071, and Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 03/18/2026 10:05:00 AM
- Ovid Therapeutics Announces Pricing of $60 Million Private Placement • GlobeNewswire Inc. • 03/18/2026 10:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2026 09:30:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2026 09:30:11 PM
- Ovid Therapeutics to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 02/25/2026 12:00:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/18/2026 01:17:42 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 01/30/2026 12:57:02 AM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 01/08/2026 04:56:04 PM
